Calvin Sternick

Stock Analyst at JP Morgan

(2.69)
# 2,078
Out of 4,761 analysts
18
Total ratings
41.67%
Success rate
9.95%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Dec 3, 2024
Maintains: Overweight
Price Target: $117$120
Current: $84.21
Upside: +42.50%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $57.68
Upside: +38.70%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $12.79
Upside: +111.10%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $180.03
Upside: +1.09%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $129.60
Upside: -37.50%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $283.81
Upside: +38.12%